Summary

Overview
The global phytoestrogen supplements market reached US$ 3.57 million in 2024 and is expected to reach US$ 5.11 million by 2033, growing at a CAGR of 4.6 % during the forecast period 2025-2033.
The global phytoestrogen supplements market encompasses the market for dietary supplements containing phytoestrogens plant-derived compounds that mimic estrogen in the body. These supplements are primarily used to alleviate symptoms related to hormonal changes, especially during menopause, and to support overall women's health.
The global phytoestrogen supplements market is poised for significant expansion due to increasing consumer awareness of women’s health issues and the demand for natural remedies for menopause-related symptoms. With a diverse range of products available across multiple applications, this market presents numerous opportunities for manufacturers and suppliers aiming to cater to health-conscious consumers.These factors have driven the global phytoestrogen supplements market expansion.
Market Dynamics: Drivers & Restraints
Increasing Demand for Natural Alternatives to Hormone Replacement Therapy (HRT)
The increasing demand for natural alternatives to hormone replacement therapy (HRT) is a significant driver in the global phytoestrogen supplements market. This trend reflects a growing preference among consumers, particularly women experiencing menopause, for safer and more natural options to manage hormonal changes and associated symptoms.
Traditional hormone replacement therapy has been effective in alleviating menopausal symptoms, such as hot flashes and mood swings. However, it is often linked to potential health risks, including an elevated risk of breast cancer, heart disease, and blood clots. As awareness of these risks increases, many women are seeking alternatives that provide similar benefits without the associated dangers.
There is a broader societal shift towards natural and holistic health solutions. Consumers are increasingly interested in dietary supplements derived from natural sources, such as plants, which are perceived as safer and more aligned with a healthy lifestyle. Phytoestrogens, found in various plant-based foods like soy, flaxseeds, and lentils, offer a plant-derived alternative to synthetic hormones.
Furthermore, key players in the industry investments and research & developments that would drive the global phytoestrogen supplements market expansion. For instance, in October 2023, NeuTherapeutics, a startup based in Tucson, secured a $2.5 million grant from the National Institutes of Health (NIH), specifically from the National Institute on Aging (NIA). This funding will support a Phase 2 clinical trial aimed at evaluating the effectiveness of PhytoSERM, a dietary supplement designed to alleviate hot flashes in menopausal women. All these factors demand the global phytoestrogen supplements market.
Also, in December 2023, the development of PhytoSERM, a selective estrogen β-receptor phytoestrogen formulation, aims to tackle two significant health issues for women: reducing the risk of Alzheimer's disease and alleviating menopausal symptoms. This initiative is currently being explored through a Phase 2 randomized clinical trial framework. Moreover, the rising demand for the growth of growth in functional foods and beverages monitoring contributes to the global phytoestrogen supplements market expansion.
Risks of Side Effects
The risks of side effects associated with phytoestrogen supplements represent significant constraints within the global phytoestrogen supplements market. Despite their increasing popularity as natural alternatives to hormone replacement therapy (HRT), concerns about safety and potential adverse effects can undermine consumer confidence and hinder market growth.Phytoestrogens can cause various side effects, including allergic reactions, abdominal pain, muscle pain (myalgia), and sleepiness. Such adverse reactions may discourage consumers from consistently using these products, which could limit market expansion.
A meta-analysis has shown that phytoestrogen supplements are linked to moderately elevated rates of gastrointestinal side effects, such as abdominal discomfort and nausea. These issues can lead some individuals to discontinue use, creating hesitance among potential users who are concerned about their digestive health.Thus, the above factors could be limiting the global phytoestrogen supplements market's potential growth.
Segment Analysis
The global phytoestrogen supplements market is segmented based on type, source, application, end-user, and region.
Type:
The flavonoids segment is expected to dominate the global phytoestrogen supplements market share
The flavonoids segment holds a major portion of the global phytoestrogen supplements market share and is expected to continue to hold a significant portion of the global phytoestrogen supplements market share during the forecast period. The flavonoids segment within the global phytoestrogen supplements market is essential due to the unique properties and health benefits associated with flavonoids, which are a subclass of phytoestrogens. This segment is anticipated to witness significant growth as consumer awareness of the benefits of phytoestrogens increases, particularly in managing menopausal symptoms and enhancing overall health.
Flavonoids are plant-derived compounds known for their antioxidant properties and ability to mimic estrogen in the body. They can be categorized into several types, including isoflavones (such as daidzein, genistein, glycitein, and biochanin A) and coumestans. Each type has distinct biological activities and health benefits, making them valuable in dietary supplements targeted at women's health. Flavonoids are particularly recognized for their potential to alleviate menopausal symptoms, including hot flashes, mood swings, and night sweats. They also contribute to cardiovascular health, support bone density maintenance, and help achieve overall hormonal balance. This makes flavonoids appealing to women seeking natural alternatives to hormone replacement therapy (HRT).
Furthermore, key players in the industry innovative launches that would drive this segment growth in the global phytoestrogen supplements market.For instance, in November 2023, Mena, launched is a new range of products that includes breads, breakfast cereals, and snack bars specifically designed to alleviate menopause symptoms. This innovative food line incorporates ingredients rich in plant estrogens, also known as phytoestrogens, which are believed to help reduce discomfort associated with menopause. By providing these phytoestrogen-rich options, Mena offers a natural food alternative for women seeking relief during this transitional phase of life.
Also, in August 2022, Vedistry launched Fortyfitt Woman Tablets, a dietary supplement specifically designed to assist women during the transition from perimenopause to menopause. These tablets feature a potent blend of soya phytoestrogens and various nutraceuticals, including green tea, ginseng, grape seed extract, and omega-3 fatty acids. These factors have solidified the segment's position in the global phytoestrogen supplements market.
Geographical Analysis
North America is expected to hold a significant position in the global phytoestrogen supplements market share
North America holds a substantial position in the global phytoestrogen supplements market and is expected to hold most of the market share. Consumers in North America are increasingly leaning towards natural and alternative health solutions. This trend is reflected in the rising consumption of dietary supplements that contain plant-derived compounds like phytoestrogens. Concerns about the side effects associated with synthetic medications have fueled this shift towards natural ingredients.
There is a heightened awareness among women regarding menopause and its associated symptoms. As more women seek relief from symptoms such as hot flashes, mood swings, and night sweats, the demand for phytoestrogen supplements has surged. These products are increasingly viewed as effective natural alternatives to hormone replacement therapy (HRT).
There has been substantial investment in research and development within the dietary supplement industry. Companies are focusing on creating innovative phytoestrogen products that cater to health-conscious consumers. This emphasis on R&D enhances product efficacy and safety, further propelling market growth.
There is an increasing trend towards nutraceuticals foods that provide health benefits beyond basic nutrition. Phytoestrogen supplements fit well within this category as they offer specific health benefits related to hormonal balance and menopausal symptom relief.
Furthermore, in this region, a major of key players presence, well-advanced healthcare infrastructure, and launches that would drive this global phytoestrogen supplements market growth. For instance, in August 2023, Designs for Health launched a new line of women's health supplements, featuring ProbioMed Women and FemGuard-HF. These products are specifically formulated to meet the unique health requirements of women throughout various life stages. Thus, the above factors are consolidating the region's position as a dominant force in the global phytoestrogen supplements market.
Asia Pacific is growing at the fastest pace in the global phytoestrogen supplements market share
Asia Pacific holds the fastest pace in the global phytoestrogen supplements market and is expected to hold most of the market share. There has been a significant rise in health awareness among consumers in the Asia-Pacific region. Many individuals are prioritizing their health and well-being, leading to increased demand for nutritional supplements, including phytoestrogens. This shift is fueled by a growing recognition of the importance of preventive healthcare, prompting consumers to seek solutions that enhance their overall health.
The region is witnessing a rapidly aging demographic, particularly in countries like Japan and China. As more individuals enter menopause, there is heightened demand for products that address age-related health issues, including hormonal imbalances. Phytoestrogen supplements are appealing because they provide natural alternatives to hormone replacement therapy (HRT) for managing menopausal symptoms.
Consumers are increasingly favoring natural and plant-based health solutions. Many are moving away from synthetic medications due to concerns about side effects and toxicity. This trend is driving demand for phytoestrogen supplements, which are derived from natural sources and perceived as safer options. The trend toward nutraceuticals—foods that provide health benefits beyond basic nutrition is gaining traction in the Asia-Pacific market. Phytoestrogens fit well within this category, offering specific benefits related to hormonal balance and relief from menopausal symptoms, thus appealing to health-conscious consumers.
Furthermore, in this region, a major of key players presence, well-advanced healthcare infrastructure, and launches that would drive this global phytoestrogen supplements market growth. For instance, in August 2022, Charak Pharma launched Fortyfitt Woman tablets, a dietary supplement specifically formulated to assist women during their transition from perimenopause to menopause. These tablets feature a potent blend of soya phytoestrogens and various nutraceuticals, including green tea, ginseng, grape seed extract, and omega-3 fatty acids. This combination aims to support overall health and well-being for women in their forties, addressing common menopausal symptoms effectively. Thus, the above factors are consolidating the region's position as the fastest-growing force in the global phytoestrogen supplements market.
Competitive Landscape
The major global players in the phytoestrogen supplements market include DōTERRA, Nutra Green, NATURAL ORGANICS INC., Solaray, Archer Daniels Midland Company, Nature's Way Deltastar, and A.Vogel among others.
Key Developments
• In August 2024, Life Extension introduced the Estrogen Balance Elite supplement. A recent survey conducted by the brand revealed that over 80% of women reported experiencing hormone-related discomfort at least once a week. This statistic highlights the commonality of issues such as hot flashes, night sweats, and mood swings, particularly during perimenopause and menopause.
• In October 2022, PharmaLinea introduced an advanced whole-body menopause supplement named Your Meno Ease. This product is specifically formulated to alleviate a variety of symptoms associated with menopause, including pain, hot flashes, and mood swings. Clinical research has shown that Your Meno Ease can reduce pain intensity by 27% compared to a placebo, highlighting its effectiveness in managing menopausal symptoms.
• In October 2022, Health & Her introduced a new line of menopause supplements that are specifically phytoestrogen-free, catering to women who wish to avoid plant-based estrogens in their dietary products. This decision addresses the growing awareness and concerns among women regarding hormone-related issues during menopause.
Why Purchase the Report?
• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
The global phytoestrogen supplements market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.
Target Audience 2023
• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.

• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.

• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.

• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.

• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.

• Supply Chain: Distribution and Supply Chain Managers.

• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.

• Academic & Research: Academic Institutions.

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Source
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Demand for Natural Alternatives to Hormone Replacement Therapy (HRT)
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. Risks of Side Effects
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs
6. By Type
6.1. Introduction
6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
6.1.2. Market Attractiveness Index, By Type
6.2. Flavonoids*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Daidzein
6.2.4. Genistein
6.2.5. Glycitein
6.2.6. Biochanin A
6.2.7. Coumestans
6.2.8. Prenyl Flavonoids
6.3. Lignans
6.4. Stilbenes
6.5. Others
7. By Source
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
7.1.2. Market Attractiveness Index, By Source
7.2. Soy Extract*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Nuts & Oilseeds
7.4. Cereals & Bread
7.5. Legumes
7.6. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Food & Beverages*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Nutraceuticals
8.4. Cosmetics
8.5. Others
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals & Clinics*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Wellness Centers
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. U.K.
10.3.7.3. France
10.3.7.4. Spain
10.3.7.5. Italy
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. South Korea
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Omron Corporation *
12.1.1. Company Overview
12.1.2. Product Portfolio
12.1.2.1. Product Description
12.1.2.2. Product Key Performance Indicators (KPIs)
12.1.2.3. Historic and Forecasted Product Sales
12.1.2.4. Product Sales Volume
12.1.3. Financial Overview
12.1.3.1. Company Revenue’s
12.1.3.2. Geographical Revenue Shares
12.1.3.3. Revenue Forecasts
12.1.4. Key Developments
12.1.4.1. Mergers & Acquisitions
12.1.4.2. Key Product Development Activities
12.1.4.3. Regulatory Approvals etc.
12.1.5. SWOT Analysis
12.2. DōTERRA
12.3. Nutra Green
12.4. NATURAL ORGANICS INC.
12.5. Solaray
12.6. Archer Daniels Midland Company
12.7. Nature's Way
12.8. Deltastar
12.9. A.Vogel
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us